Subscribe to RSS - BioScrip

BioScrip

Short takes: BioScrip, BOC, Mediware, NASP

 - 
02/08/2017

BioScrip has joined Keep My Infusion Care at Home, a coalition formed in response to a change in the payment model for Medicare Part B home infusion drugs. The Denver-based BioScrip is a leading provider of infusion and home care management solutions

In brief: Bid relief becomes official, BioScrip restructures credit

 - 
12/16/2016

WASHINGTON – President Barack Obama on Dec. 13 signed into law the 21st Century Cures Act, which offers some relief to HME providers in rural areas.

BioScrip restructures credit

 - 
12/14/2016

DENVER – BioScrip has announced a plan to increase its liquidity.

Turnaround king?

Daniel Greenleaf rolls up his sleevs
 - 
11/23/2016

Daniel Greenleaf is in a familiar position. The new president and CEO of BioScrip is tasked with turning around an underperforming home infusion company, which he did with both Coram and, more recently, with Home Solutions.

BioScrip ‘took its eye off the ball’

 - 
11/11/2016

DENVER – With revenues at BioScrip sliding again in the third quarter, new President and CEO Daniel Greenleaf didn’t mince words on a recent earnings call.

In brief: Contract supplier pays $12M, CMS revises enrollment application

 - 
09/09/2016

NEWARK, N.J. – U.S. Healthcare Supply, a national contract supplier for mail-order diabetes supplies, and two of its executives have agreed to pay the government more than $12.2 million to resolve allegations that they violated the False Claims Act.

BioScrip, Home Solutions tweak deal

 - 
09/06/2016

DENVER – The price tag for BioScrip’s acquisition of Home Solutions has dropped from $85 million to $75 million, according to news reports.

BioScrip completes offering

 - 
06/22/2016

DENVER – BioScrip has completed a public offering of common stock, netting approximately $83.15 million.

BioScrip makes buy, announces public offering

 - 
06/17/2016

DENVER – BioScrip, a provider of infusion and homecare management solutions, has entered into an agreement to buy the business of HS Infusion Holdings.

BioScrip makes buy, announces public offering

 - 
06/14/2016

DENVER – BioScrip, a provider of infusion and homecare management solutions, has entered into an agreement to buy the business of HS Infusion Holdings.

Pages